Voyager Therapeutics, Inc. (31) | License Agreements (4)

Recent Contracts

Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022 (Filed With SEC on May 4, 2022)
Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021 (Filed With SEC on November 2, 2021)
First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020 (Filed With SEC on November 9, 2020)
Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)